Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 1
Results: 15
Effectiveness of long‐term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 109, doi. 10.1111/ejh.13778
- By:
- Publication type:
- Article
Screening of the protein C pathway abnormality‐related thrombophilia by using thrombomodulin‐mediated tissue factor‐triggered clot waveform analysis.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 100, doi. 10.1111/ejh.13777
- By:
- Publication type:
- Article
Retracted: Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B‐cell non‐Hodgkin's lymphoma.
- Published in:
- 2022
- Publication type:
- Correction Notice
A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 90, doi. 10.1111/ejh.13775
- By:
- Publication type:
- Article
Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures (PROMs).
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 3, doi. 10.1111/ejh.13774
- By:
- Publication type:
- Article
Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first‐line treatment for patients with diffuse large B‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 41, doi. 10.1111/ejh.13767
- By:
- Publication type:
- Article
Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 31, doi. 10.1111/ejh.13766
- By:
- Publication type:
- Article
Mixed T cell CHIMERISM in bone marrow at day+30 after allogeneic stem cell transplantation: Correlation with acute GVHD grades III–IV and no impact on relapse and overall survival.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 83, doi. 10.1111/ejh.13772
- By:
- Publication type:
- Article
Bone metabolism parameters and their relation to cytogenetics in multiple myeloma.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 75, doi. 10.1111/ejh.13771
- By:
- Publication type:
- Article
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 58, doi. 10.1111/ejh.13769
- By:
- Publication type:
- Article
Direct oral anticoagulants versus warfarin in patients with single antibody‐positive anti‐phospholipid syndrome.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 69, doi. 10.1111/ejh.13770
- By:
- Publication type:
- Article
Primary radiation therapy in stage I/II indolent orbital lymphoma – a comprehensive retrospective recurrence and toxicity analysis.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 21, doi. 10.1111/ejh.13765
- By:
- Publication type:
- Article
Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow‐up.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 10, doi. 10.1111/ejh.13764
- By:
- Publication type:
- Article
Multistep pathogenesis of chronic myelomonocytic leukemia in patients.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 50, doi. 10.1111/ejh.13768
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 1, doi. 10.1111/ejh.13657
- Publication type:
- Article